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Summary Oxytocin (OT) activity increases in response to stress as well as to warm social contact.
Subclinical depression is associated with higher stress but less reward from social contacts. The
present investigation was intended to examine whether husbands and wives with high depressive
symptomatology scores have increased plasma and salivary OT that may be mediated partly by
higher perceived stress, and also to assess whether an intervention to convey partner support
through ‘‘warm touch’’ may reduce effects of depressive symptoms on OT. In this study, 34 healthy
married couples (n = 68) ages 20—39 provided self reports of depressive symptoms (CESD) and stress
(Perceived Stress Scale) before being randomly assigned to a 4-week intervention study enhancing
partner support through ‘‘warm touch’’, or to a ‘‘behavior monitoring’’ control group. Plasma
oxytocin levels were obtained pre- and post-intervention, while salivary oxytocin was taken at home
during week 1 and week 4. Results revealed that subjects with higher depressive symptoms scores
had higher plasma OT levels at pre-intervention, and higher salivary OT levels at home during week 1
( p < .05). Plasma OT results were moderated by gender such that plasma OT levels were highest
among females high in depressive symptomology. Higher perceived stress was also linked to both
higher depressive symptomatology (r = + 65, p < .0001) and plasma OT ( p < .05) and a significant
mediator. During the intervention, salivary OTremained elevated among subjects high in depressive
symptomatology in the control group but not the intervention group. At post-intervention, plasma
OT levels in subjects with vs. without depressive symptomatology no longer differed. Results
indicate that subclinical depression is associated with elevated plasma and salivary OT levels, which
may be mediated in part by increased stress. OT differences linked to subclinical depression were
minimized by the warm touch intervention.
# 2011 Elsevier Ltd. All rights reserved.
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1. Introduction
The role of oxytocin (OT) in formation of pair bonds is well
established in non-human mammalian species (Carter, 1998;
Young and Wang, 2004). For this reason, OT has received
considerable recent attention in human research focused on
family relationships and attachment quality. On the surface,
however, the findings appear paradoxical. Some studies have
observed higher plasma OT levels in men and women reporting more supportive relationships with spouses or parents
(Gordon et al., 2008; Grewen et al., 2005; Light et al., 2005;
Tops et al., 2007a; Turner et al., 1999); however, two of these
same studies and several others also reported that higher OT
levels were associated with anxiety or distress about social or
romantic attachments (Marazziti et al., 2006; Taylor et al.,
2006)(Gordon et al., 2008; Hoge et al., 2008; Taylor et al.,
2010; Tops et al., 2007b).
One way to integrate these reports linking higher OT
linked to both positive relationships and to ambivalent or
distressing relationships is to consider the multiple roles of
OT activity. In addition to its role in attachment and bonding,
OT has been repeatedly shown in animal models to be
activated by stress and anxiety-inducing stimuli, and thereby
modulates and inhibits both sympathetic nervous system and
hypothalamic-pituitary-adrenal stress activity (Amico et al.,
2004; Ring et al., 2006; Windle et al., 2004). Helping to
synthesize these two aspects of OT activity are studies
indicating that endogenous or exogenous OT administration
reduces anxiety behaviors in rodents via activation of OT
receptors on serotonergic neurons (Slattery and Neumann,
2010; Waldherr and Neumann, 2007; Yoshida et al., 2009) and
enhances inhibition of central amygdale by diazepam (Viviani
et al., 2010). Such studies have led to suggestion that OT
administration might also be beneficial as adjunctive treatment for social anxiety disorder (Guastella et al., 2009;
Rotzinger et al., 2010).
In human depression, it is equally plausible that plasma OT
levels would be low due to reduction in the rewarding aspects
of social contacts or elevated due to increase in perceived
stress. Recent research has been relatively consistent, however, in showing that most patients meeting criteria for major
depressive disorder demonstrate elevated levels of plasma
OT (Cyranowski et al., 2008; Parker et al., 2010; Scantamburlo et al., 2007). In the most extensive study of depression,
Cyranowski et al. (2008) found that although the average
plasma levels of OT were higher in unmedicated female
depressed patients than controls, the difference was due
to a subgroup of those with depression who showed huge
pulsatile increases in OT even during quiet isolation while
other patients did not. To date, however, no investigations
have examined subclinical depression and whether it is also
related to increased vs. decreased OT. Furthermore, no study
has clarified whether effects of depression on OT are primarily linked to increased perceived stress levels, or whether
increased perceptions of stress have separate and independent effects on OT activity.
Previously, we (Holt-Lunstad et al., 2008) studied OT,
sympathetic and blood pressure changes produced by a 4week intervention to increase support expressed through
‘‘warm touch’’ vs. a monitoring-only control condition in
34 married couples. The present report uses the data from
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this investigation to examine the following hypotheses: (1)
that subclinical depression in married women and/or men
is associated with increased plasma OT prior to the start of
intervention; (2) that higher perceived stress is linked to
both higher depressive symptoms and to higher OT, and
may be a partial mediator of the relationship between the
other 2 factors; (3) that the ‘‘warm touch’’ intervention
reduces differences in OT associated with subclinical
depression and/or perceived stress, providing evidence
that this type of intervention is effective in normalizing
physiological responses among stressed or mildly depressed
individuals.

2. Method
2.1. Participants
Participants and procedures have been described in detail
previously (Holt-Lunstad et al., 2008). To summarize briefly,
34 healthy married couples (n = 68) married 6 months or more
were recruited from the community (age: mean = 25.2;
SD = 3.8 years, range 20—39 years) and completed the
screening and one month protocol. Couples were randomized
into two groups, with 20 couplesin the intervention group and
14 couplesin the ‘‘monitoring only’’ control group. Recruitment of subjects and study protocol were approved by the
university IRB committee.

2.2. Procedures
After randomization, couples in both groups underwent
similar physiological assessment procedures before and
after the 4-week intervention/behavioral monitoring period. Plasma OT was obtained once pre- and post-intervention. The effects of the intervention on OT activity were
also assessed by comparing salivary OT obtained at home
once during week 1 and twice during week 4 of the intervention/monitoring period. After consent was obtained,
participants completed a packet of questionnaires that
assessed standard variables that may influence health
(e.g., demographics, health history) as well as depressive
symptoms (Center for Epidemiological Studies Depression
Scale or CESD) and recent life stress (Perceived Stress
Scale). These questionnaires were completed once at
the pre-intervention testing. OT measures: a pretreatment
blood draw for plasma OT obtained via venipuncture was
made after each couple sat close together for 5 min holding hands. For salivary OT, saliva samples were obtained at
home on 3 occasions: saliva sample 1 was taken during the
first week of the intervention/monitoring period, while
samples 2 and 3 were both taken during the fourth week
of the intervention/monitoring period, on different days.
The intervention couples were instructed to obtain all
three saliva samples at home on evenings when they
practiced the warm touch techniques, while the controls
were simply told to collect their samples during evenings
spent at home. All couples were called by a research
assistant during this time and reminded to do this. Participants were instructed to freeze the saliva samples immediately, and then all three frozen samples were returned to
the lab at the time of the post-intervention procedure.
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2.2.1. Outline of intervention, home practice and
post-intervention testing protocol
Couples randomized to the intervention group were asked to
come into the lab in groups of 3—5 couples, for two 1-h
training sessions During the first session (week 1 of the
intervention) couples were trained in Rosen Method Listening
Touch where one increases awareness of the partner’s mood
and body state through touching their partner’s neck,
shoulders and hands, first while the partner was seated in
front of them and then while both partners stood together
back to back, gradually initiating a slow rocking motion.
Then, they were given an audio recording to guide them in
practicing these techniques at home, and were instructed to
practice for 30 min 3 times/week for 4 weeks, and to keep
records of when they practiced and their mood state before
and after practice. During the second session (week 2 of the
intervention) couples watched a short video of actors showing examples of sensitive and insensitive touch, followed by a
second video demonstrating neck, forehead and shoulder
massages. Couples were then asked to follow along with
the massage video, practicing with their spouse under supervision of a trained staff member. Couples were given the
option either to add massage to their practice or to replace
the listening touch practice with massage during weeks 2—4.
In the Control Group, subjects were told not to change
anything about their normal behavior with their spouse
and to simply keep a diary of their physical affection and
mood. They were asked to report this once a week for 4
weeks. For both the intervention and control groups, monitoring of warm touch had to be recorded online on a fixed
schedule to prevent confabulation errors associated with
retrospective recall.

2.3. Measures
2.3.1. Medical and demographic information
(Volunteer Health Questionnaire)
Subjects completed an in-house form assessing all relevant
health variables, plus occupation, education, and total
family income.
2.3.2. Center for Epidemiological Studies Depression
Scale (CES-D)
The CES-D includes 20 clinically derived items and appears to
be a reliable and valid measure of depression (Radloff, 1977).
In a nationwide survey of 2500 participants, the scale’s
reliability showed high consistency, ranging from .75 to.95
(Cronbach’s alpha).
2.3.3. The Perceived Stress Scale (PSS)
This widely used scale is a ten-item assessment designed to
measure perceived stress exposure and severity over the past
month. It has been demonstrated to have adequate psychometric properties and is related to other stress, health, and
satisfaction measures (Cohen et al., 1983).
2.3.4. Oxytocin sampling and bioassay procedures
As previously described, a pre- and post-treatment plasma
sample for OT was obtained directly from a single-stick
venipuncture after 5 min of close warm couple contact,
and the 3 home saliva samples for OT were obtained by using
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unstimulated passive drool collected into 4 ml plastic tubes.
Participants were asked to spit into the tube until full.
Samples were immediately frozen at the subjects’ homes,
transported still frozen to the lab and then shipped to the
University of North Carolina for assay using enzyme immunoassay (EIA) methods using an OT EIA kit from Assay Designs
(Ann Arbor, Michigan, USA). For salivary OT, the methods used
were similar to those developed for salivary OT and validated
by Carter et al. (2007), with the addition of an extraction
step that was required because Assay Design is now using a
new and different OT antibody from the one they used. This
new OT antibody now requires an extracted sample, because
as stated in the new kit instructions, this new antibody gives
much lower precision without an extracted sample. The
extraction reduces matrix interference and, through evaporation, concentrates the sample 3.2 times, which is very
similar to the 4.0 times concentration produced by Carter’s
full dry-down procedure (Carter et al., 2007). In this study,
the extraction efficiency was 101.6% and intra assay variability was 4.8% obtained from both saliva and plasma samples, since all of these samples were extracted and assayed in
the same batch at the same time. Saliva OT and plasma OT
have been shown to similarly discriminate breast-feeding
from bottle-feeding mothers of infants, and to correlate
reliably with each when obtained in the same time period
(Grewen et al., 2010).

2.4. Primary analyses
We used Proc Mixed (SAS Institute; Singer, 1998; Little et al.,
1996) to estimate random intercept models with random
effects for couples. Kenny and colleagues (Kenny et al.,
2006) proposed a model of dyadic data analysis that uses
the dyad as the unit of analysis. This model suggests that a
person’s independent variable score affect both one’s own
dependent variable score (i.e., actor effect) and the partners’ dependent variable score (partner effect). As such,
analyses directly model the interdependence of husbands’
and wives’ data. In our analyses, gender and intervention
condition were first centered at their grand mean before
inclusion into the model. Separate analyses were performed
examining the impact of each of the psychological variables
(e.g., depressive symptomatology and stress), the intervention, gender and their statistical interactions on plasma and
salivary oxytocin levels.
Depressive symptomatology was treated categorically
based on empirically derived clinical cut-offs, such that
CES-D scores 8 indicate presence of subclinical or clinical
depression. (Cohen et al., 2010). CESD scores among this
sample ranged from 1 to 32 (mean = 9.02; median = 7.5).
Approximately half of our sample (49.3%) had a CESD scores
8, of which 7 participants (roughly 10% of total sample) had
scores 16 (clinical depression). We found no significant
gender difference for either CESD scores ( p = .89) or for
depression classification ( p = .63). The mean CESD score
for males was 9.32 (sd = 6.91) and the mean for females
was 8.72 (sd = 6.45). Because no such clinical cut-offs exist
for stress, the total PSS score was treated continuously. For
salivary OT, all samples were obtained at home after the
intervention or monitoring period had begun. Because we
wanted to examine whether a single week of enhanced warm
contact was sufficient to increase OT activity, we first com-

1252

J. Holt-Lunstad et al.
25

18
16

20
Plasma OT
O (pg/ml)

Plasma OT (pgg/ml)

14
12
10
8
6
4

15
W
Women

10

Men

5

2
0

0

Figure 1
sion.

Low depression

High Depression

Pre-intervention plasma oxytocin by level of depres-

pared the influence of the psychological variables at week 1
salivary OT levels. Then, to examine whether additional
practice of the techniques would further alter effects of
depressive symptomatology on OT activity, group differences
in the mean of samples 2 and 3 obtained during the final week
of the intervention or monitoring period were examined
before and after controlling for week 1 OT levels. Correlations between measures were computed as Pearson productmoment correlations. For pre-intervention baseline characteristics of our groups see Holt-Lunstad et al. (2008). All
analyses were two-tailed and data are reported in un-standardized regression coefficients.
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Figure 2 Pre-intervention plasma oxytocin according to gender and level of depression.
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3. Results
3.1. The influence of depressive
symptomatology on oxytocin
We find a significant effect of depressive symptomatology on
plasma OT (F = 11.69; p < .01), such that those high in depressive symptoms had significantly higher plasma OT than those
low in depressive symptoms (see Fig. 1). There was also a
significant gender effect (F = 4.39; p < .05) such that females
had significantly higher plasma OT (M = 11.23; sd = 1.15) than
males (M = 8.06; sd = 1.17). There was also a significant
depressive symptomatology by gender interaction on plasma
OT (F(1,31) = 4.71; p < .05). The simple effects reveal that
depressed women had the highest OT compared to depressed
men or non-depressed women (see Fig. 2).
We also found a significant main effect of depressive symptomatology on salivary OT taken during the first week of the
intervention (F(1,25) = 9.13; p = .01) such that when controlling for gender, high depressive symptomatology was associated with higher salivary OT than non-depressed (see Fig. 3).
We found no main effect of gender nor a gender by depressive
symptomatology interaction for salivary OT ( p > .10).

Figure 3 Week 1 salivary oxytocin according to gender and
level of depression.

reports of the severity of perceived stress and depressive
symptomatology are significantly correlated (r = .65;
p < .0001). Therefore, we repeated our analyses examining
effects of perceived stress on plasma and salivary OT.
We found a significant effect of perceived stress for
plasma OT (b = .42; F = 9.74; p < .01) such that higher stress
was associated with higher OT. Since we hypothesized that
higher stress was a potential mediating factor in the relationship between depressive symptomatology and OT, we reexamined the relationship between depressive symptomatology and pre-intervention plasma OT after controlling for
perceived stress. Adjusting for stress substantially weakened
the effect of depressive symptomatology on plasma OT so
that it was no longer significant ( p > .10). Further, the
Sobel’s test of mediation was significant (2.16; SE .12;
p = .03), suggesting that the association between depressive
symptomatology and plasma OT may be partly mediated by
perceived stress. There was no significant effect of stress on
week 1 salivary OT ( p > .20).

3.2. The influence of stress as a potential
mediator

3.3. The influence of the warm touch
enhancement intervention

A second aim is to examine whether greater perceived stress
may explain why depressive symptomatology influences OT
and physiological stress activation. We found that self-

3.3.1. During the intervention
Salivary OT was first obtained during the initial week of the
intervention, not prior to the intervention as was done for
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intervention assessments adjusting for pre-intervention
levels ( p > .20) (Table 1).
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Figure 4 Week 1 salivary oxytocin according to intervention
group and level of depression.

plasma OT. For week 1 salivary OT, there was a significant
depressive symptomatology by condition interaction
(F = 8.22; p = .02). Similar to the plasma OT finding, among
the control group those high in depressive symptoms had
significantly higher salivary OT than those low in depressive
symptoms ( p < .05). In the intervention group, after just 1
week of training and home practice, salivary OT did not differ
significantly between the high and low depressive symptomatology subjects. This effect was most pronounced among
the women with high depressive symptomatology scores (see
Fig. 4).
The main effect of depressive symptomatology on salivary
OT that was significant during week 1 of the intervention was
no longer significant at week 4 ( p = .17). In contrast, the
interaction between depressive symptomatology and intervention condition remained significant (F(1,11) = 4.82;
p = .05) such that differences in depressive symptomatology
persisted in the control condition but did not differ in the
intervention condition. When we adjusted week 4 salivary OT
for week 1 levels, the interaction was no longer significant
( p > .20), suggesting that there was no further enhancement
of the effect of the intervention on depressive symptomatology group differences in salivary OT between weeks 1 and 4.
3.3.2. Post-intervention
Initial differences in plasma OT based on depressive symptomatology or perceived stress were no longer present at the
completion of the intervention ( p > .20). Likewise, there
were no significant main effects or interactions involving
depressive symptomatology or stress on any of the post-

Table 1

Consistent with prior studies involving patients with major
depressive disorder (Cyranowski et al., 2008; Parker et al.,
2010; Scantamburlo et al., 2007), the present investigation
found that married men and women with subclinical depression as indexed by high CESD scores had higher pre-intervention levels of plasma OT than those with low scores. Although
present in men as well, this effect was particularly pronounced among the married women with high symptoms of
depression. Men and women with higher depressive symptomatology scores also had higher week 1 salivary OT levels.
As predicted, higher perceived stress scores were jointly
related to both pre-intervention plasma OT and to depressive
symptomatology score. The Perceived Stress Scale quantifies
the individual’s feelings of being exposed to stressful life
events during the past month. The significant test of mediation
supports the interpretation that the elevated OT in the depressive symptomatology group was in part due to increased stress.
As described previously, OT increases during stress have been
observed in animal models (Amico et al., 2004; Ring et al.,
2006; Windle et al., 2004). Among mothers of infants, we have
likewise observed significant increases in plasma OT immediately following psychological stressors (Light et al., 2000;
Grewen and Light, submitted for publication). The elevated
OT activity thus may be a response to excessive stress effects
experienced in subclinical depression that outweigh any influence of the social or bonding aspects of the environment.
In subjects randomized to the warm contact enhancement
intervention, depressive symptomatology group differences
in salivary OT levels were no longer significant as early as the
first week of the intervention, and this finding was true during
the last week as well. In the control condition, however,
subclinical depression was related to higher salivary OT
during both weeks 1 and 4. Furthermore, there were no
significant differences in plasma OT levels between high
and low depressive symptomatology groups at post-intervention controlling for pre-intervention levels.
Altogether, these findings suggest that the warm touch
enhancement intervention had a measurable beneficial
effect in lowering stress-enhanced OT among the men and
women with subclinical depression. This adds to the findings
of the beneficial physiological changes previously reported
for this intervention (Holt-Lunstad et al., 2008), which in

Sample characteristics prior to intervention by group assignment and depression level.
Intervention group

Age
BMI
Stress
Plasma OT

Control group

p-Value

Low DS n = 19
SEM
M

High DS n = 21
M
SEM

Low DS n = 15
M
SEM

High DS n = 13
M
SEM

26.04
24.49
19.37
8.03

26.31
24.17
25.38
11.86

24.07
24.25
21.26
5.75

22.47
21.37
29.78
15.74

.89
1.11
1.36
1.55

.88
1.04
1.36
1.55

.97
1.03
1.35
1.49

1.35
2.03
2.65
3.07

p = .19
p = .34
p = .47
p = .15

DS: depressive symptomology; Low DS = CESD scores < 8; High DS = CESD  8; M: mean; SEM: standard error of the mean; BMI: body mass
index; p-values are based on two-tailed tests. p-Value reflects the significance of the interaction between depression and group assignment.
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addition to increased salivary OT levels also included
decreased sympathetic activity in both husbands and wives
as indexed by lower salivary alpha amylase throughout a 24 h
sampling period and lower 24 h ambulatory blood pressure in
the men. It is important to note that our original report
stated that there were increases in salivary OT but no reliable
increase in plasma OT in the intervention group vs. the
controls following the month of warm touch home practice.
When we re-analyzed that result controlling for depressive
symptom score, we found that the intervention group did
show reliably greater post-intervention plasma OT compared
to the control group. It is thus extremely important in studies
of this kind to assess and control for depressive symptomatology and/or stress, which otherwise might obscure the
effects of social contact and support on OT activity. Furthermore, the present study confirms that individuals who are
higher in depressive symptoms can respond beneficially to
this type of warm touch based support enhancement intervention. As post hoc analyses, we found that the husbands
with high as well as low depressive symptoms showed similar
reductions in ambulatory BP, and women and men with and
without subclinical depression showed similar reductions in
salivary alpha amylase after the intervention.
As described earlier, the association between OT and
stress may appear paradoxical. Elevations in oxytocin are
linked both to reductions is stress as well as an indicator of
stress. For instance, there are data to demonstrate that
elevations in OT are linked to relaxation and calm (McCarthy,
1995), that OT inhibits stress-induced HPA response, and is
associated with affiliative behavior (Scantamburlo et al.,
2009). Conversely, studies have linked elevations in OT to
relationship distress in women (Taylor et al., 2006, 2010;
Turner et al., 1999) and is found experimentally in animals
(Grippo et al., 2009). To reconcile such divergent findings it
has been argued that OT may restore biological balance
through reciprocal modulation (Legros et al., 1982; Scantamburlo et al., 2009). Thus, OT may increase in response to
stress as a counterbalance — to calm the physiological system
and promote affiliative connection. Given that social withdrawal is characteristic of depression, elevations in OT found
among those high in depressive symptoms may be a corrective response to trigger increased affiliation.
We acknowledge several important limitations to our
study. First, because our measurements were of peripheral
OT, it is unclear to what extent OT in the periphery is
reflective of central OT. Additionally we used a fairly homogeneous population of young, healthy married couples that
was primarily Caucasian and educated. Therefore, whether
the effects we found would be generalizable to other populations would require further study, including those with
major depressive disorder or subclinical postpartum depression. In patients with a clinical diagnosis of major depression,
based on several recent reports, it appears equally likely that
this population may have lower OT (Ozsoy et al., 2009; Garcia
et al., 2010) as to have higher OT levels than controls (Parker
et al., 2010). Even when dealing with subclinical depression,
findings from different samples may differ. When our own
research group studied new mothers with vs. without subclinical postpartum depression (Light et al., 2010), we found
that those with higher depression scores showed marginally
decreased leukocyte gene expression of OT receptors while
the OT prepropeptide levels were unchanged and serotonin
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receptor 1-a and 1-d expression was increased. Another
potential limitation is that we only assessed stress and
depression at the pre-intervention assessment so we cannot
determine whether the intervention may have led to reductions in perceived stress or depressive symptomology.
Further, the Perceived Stress Scale does not differentiate
social from non-social stressors. Research reveals that social
stressors have more of an influence on the HPA and thus more
toxic than non-social stressors (Dickerson and Kemeny, 2004),
therefore it is possible that oxytocin may be particularly
sensitive to social stressors. Finally, we acknowledge that in
some instances, current perceived stress and/or anxiety
levels may be equally important or more important to consider. For example, in unmarried young adults, Keri and Kiss
(2011) observed that plasma OT levels were more strongly
associated with state anxiety than with depressive symptom
scores.
Men and women with subclinical depression may be an
important high risk group to examine as they may be predisposed to multiple unfavorable conditions. For instance, in a
prospective study among older adults it was found that
among those with subclinical depression at the outset of
the study, 84% were clinically depressed at a 33 month
follow-up (Cohen et al., 2010). Research among a community
cohort of women found that post-partum major depression
could significantly be predicted by prior depressive symptoms
and not breastfeeding at an 8-week follow up (Davey et al.,
2008). There is also a well-documented association between
depression and cardiovascular disorders (Grippo and Johnson, 2009; Mosovich et al., 2008; Van der Kooy et al., 2007).
Depressive symptoms have also been significantly predictive
of subclinical atherosclerosis (Seldenrijk et al., 2010; Spitzer
et al., 2008). Intervening among those with subclinical
depression may prevent the transition to severe and persistent depression; and possibly reduce risk for cardiovascular
outcomes.
Our findings support the hypothesis that dysregulated OT
may be a biomarker of emotional distress which characterize
major depression (Parker et al., 2010). These findings extend
prior studies by demonstrating that the disruption in OT
associated with depressive symptomatology may be strongest
among women. Sexual dimorphism has been widely documented in response to both acute and chronic stressors
(Grippo et al., 2007; Klein and Corwin, 2002; McCormick
et al., 2005). Sex differences are also seen in prevalence,
presentation, etiology of depression (Grigoriadis and Robinson, 2007). However, despite relative sex differences,
depression afflicts both men and women; thus, examining
OT among both sexes may provide further understanding the
pathophysiological mechanisms.
This study is the first known study to submit that an
intervention may be effective in ‘‘normalizing’’ disruptions
in OT levels due to depression in humans. Prior research
found that although depression was associated with deregulated serum oxytocin levels relative to controls, anti-depressant and electroconvulsive shock therapy did not significantly
alter oxytocin levels among those with either major depression or bipolar disorder (Ozsoy et al., 2009). In mice, however, it was found that sexual activity and mating reduced
depressive behaviors in wild type male mice that was not
seen in OT receptor-deficient mice (Matsushita et al., 2010).
Oxytocin was reported to have had an antidepressant-like
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effect. Although our intervention involved non-sexual touch,
the couple’s massage component of the intervention may
mimic such intimate physical affection. Given the prevalence
of treatment resistant depression (Hughes and Cohen, 2009),
successful intervention among those high risk prior to developing clinical depression may be particularly important to
examine further. Overall, these findings have implications for
the role of oxytocinergic mechanisms as potential interventions that target this regulatory peptide in the management
and treatment of depressive disorders.
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